AROMATASE INHIBITORS

Course overview

ANASTROZOLE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF BREAST CANCER. IT IS IN THE AROMATASE INHIBITORS CLASS OF DRUGS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ANASTROZOLE AS A VALUABLE AGENT IN MANAGING ADVANCED HORMONE-RECEPTIVE BREAST CANCER. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH BREAST CANCER AND RELATED CONDITIONS.